Curis

Developer of therapeutics by targeting different signaling pathways to treat multiple cancers

placeLexington, Massachusetts, United States calendar_todayFounded 2000 groups49 employees language curis.com

Registered entities

Innovation

147 patent families (92 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing, Emerging technologies; filing pace steady. Cited 12,704 times.

YearFilings
201523
201617
201715
201813
201917
202014
20218
202211
202313
202412
202513
20262

Social engagement

Social engagement: 6.6K social following, 3 posts in the last 12 months — below the industry typical range.

Investor mix

5 investors on record; 1 has since exited.

Investor typeCountShare
Venture capital120%
Private equity240%
Bank & private debt120%
Other / undisclosed120%

Recent activity

2 Jul 2026
Partnership
CLL Society
14 Nov 2025
Event
2025 Society for Neuro-Oncology (#SNO2025) Annual Meeting
Coming soon